<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Ep 52: Mental Health, Cancer, and the Gut Data We’re Not Using</title>
  <description>We talk a lot about “data-driven healthcare,” yet we’re still blind to one of the most important data layers: the microbiome. Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don’t account for it. In this episode of Boombostic Health, I sit down with Paul Denslow, CEO &amp;amp;amp; co-founder of Intus Bio, to dig into how GutID turns the microbiome into hard infrastructure: high-resolution gut data, a score you can track, and a way to see whether your interventions are actually moving risk—not just spend.  In this episode, we cover:   Why microbiome disruption often precedes mental health issues and cancer   How GutID converts millions of bacterial data points into a single, trackable gut score   Why behavioral health and functional practitioners have been early adopters   The problem with “just take a probiotic” in the absence of baseline gut data   How AI + high-resolution microbiome testing open a real prevention window   What a serious prevention and longevity strategy looks like when gut data is included   If you’re responsible for care delivery, benefits strategy, or long-term risk, ignoring this data layer is no longer a neutral decision. Watch the full conversation to see why mental health, cancer, and your “bacterial you” belong at the center of modern prevention. &amp;amp;nbsp; About our guest: Paul Denslow is the CEO and co-founder of Intus Bio, the company behind GutID. With a background in finance and big data, Paul partnered with co-founder Mark Driscoll, a pioneer in next-generation sequencing, to build a platform that treats the microbiome as a hard data problem—not a mystery. Intus Bio’s GutID test and Titan 1 platform are used by clinicians and practitioners to generate high-resolution microbiome data that can be translated into actionable prevention and disease insights. Links &amp;amp;amp; Resources: Learn more about GutID: https://www.gutid.com/collections/all Learn more about Intus Bio: https://www.intusbio.com/gutid Watch more Boombostic Health episodes: https://www.boombostichealth.com/podcast </description>
  <author_name>Boombostic Health</author_name>
  <author_url>https://sites.libsyn.com/562385</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39168780/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/195825685</thumbnail_url>
</oembed>
